Novo Nordisk A/S buy Luise1
Summary
This prediction ended on 12.05.14 with a price of €31.33. The BUY prediction by Luise1 finished with a performance of 25.74%. Luise1 has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novo Nordisk A/S | - | - | - | - |
iShares Core DAX® | -3.429% | 5.085% | 15.455% | 12.600% |
iShares Nasdaq 100 | -6.121% | 0.593% | 16.379% | 27.048% |
iShares Nikkei 225® | -7.364% | 5.479% | 6.970% | -3.061% |
iShares S&P 500 | -4.366% | 2.019% | 18.650% | 32.317% |
Comments by Luise1 for this prediction
In the thread Novo Nordisk A/S diskutieren
Medizin für die, die gut leben
ein champion, der schon zu lange seitwärts läuft und darauf wartet nach oben auszubrechen!
wie viele haben einen erhöhten zucker-wert, wer benötigt bereits hilfe? wenn dann von
novo nordisk!
Stopped prediction by Luise1 for Novo Nordisk A/S
Novo Nordisk A/S
14.09.19
04.11.21
05.11.21